Status:
UNKNOWN
ATG5 as a Serum Marker of Autophagy in Psoriatic Patient
Lead Sponsor:
Sohag University
Conditions:
Psoriasis Vulgaris
Autophagy
Eligibility:
All Genders
18-55 years
Brief Summary
it will be of interest to know the ATG 5 as a serum marker of autophagy in serum of psoriasis vulgairs patients and explore its relationship with psoriasis severity.
Eligibility Criteria
Inclusion
- Psoriasis vulgaris of both sex, age 18-55 years
Exclusion
- i. Patients with other types of psoriasis ii. Pregnant or lactating women iii. patients with hepatic or renal diseases iv. patients receive any systemic treatment in last 3 months
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05279638
Start Date
February 1 2022
End Date
January 1 2024
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt